ClinicalTrials.govpublic full text
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
immunotherapy, hyperprogression, biomarker
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 160368
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.